James T. Treace, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 45,820 shares at $23.00 ($1.1M) on 2023-01-30, disclosed to the SEC on 2023-01-30.
Open-market sale of $1.1M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 28,214 | $649K | 60.9% |
| 2 | $23.68 | 8,803 | $208K | 19.6% |
| 3 | $23.68 | 8,803 | $208K | 19.6% |
| Total | $23.26 avg | 45,820 | $1.1M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-30 | $130K | — | Filing → |
| TMCI | BUY | 2024-05-29 | $254K | — | Filing → |
| TMCI | BUY | 2024-05-13 | $1.0M | — | Filing → |